Cargando…
Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics
The most common malignant tumor of the brain is glioblastoma multiforme (GBM) in adults. Many patients die shortly after diagnosis, and only 6% of patients survive more than 5 years. Moreover, the current average survival of malignant brain tumors is only about 15 months, and the recurrence rate wit...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875488/ https://www.ncbi.nlm.nih.gov/pubmed/35214188 http://dx.doi.org/10.3390/pharmaceutics14020456 |